{"id":12130,"date":"2025-03-13T21:03:33","date_gmt":"2025-03-13T20:03:33","guid":{"rendered":"https:\/\/valintermed.com\/?p=12130"},"modified":"2025-03-13T21:03:33","modified_gmt":"2025-03-13T20:03:33","slug":"multifokalnyy-fibroskleroz","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/multifocal-fibrosclerosis\/","title":{"rendered":"Multifocal fibrosclerosis"},"content":{"rendered":"
<\/div>\n

Multifocal fibrosclerosis (MFS) is a rare disease characterized by multiple fibrous changes in various tissues and organs, which leads to dysfunction. The main pathomorphological sign of MFS is the proliferation of fibroblasts with the formation of fibrous connective tissue, which can accumulate in the lungs, liver, kidneys, middle wall of large vessels and other organs. This disease can be associated with various infections, autoimmune and metabolic disorders, which complicates its diagnosis and management. It is estimated that MFS is a complex combination of various factors affecting its manifestation and development, which requires an integrated approach to assessment and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n